Terms: = Kidney tumors AND PRRX1, ENSG00000116132, 5396
4 results:
1. SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent manner.
Wang T; Wagner RT; Hlady RA; Pan X; Zhao X; Kim S; Wang L; Lee JH; Luo H; Castle EP; Lake DF; Ho TH; Robertson KD
Mol Oncol; 2024 Jan; 18(1):44-61. PubMed ID: 37418588
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant expression of vasculogenic mimicry, prrx1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance.
Wang X; Yang R; Wang Q; Wang Y; Ci H; Wu S
Medicine (Baltimore); 2019 Sep; 98(36):e17028. PubMed ID: 31490389
[TBL] [Abstract] [Full Text] [Related]
3. Percutaneous microwave ablation for local control of metastatic renal cell carcinoma.
Maciolek KA; Abel EJ; Best SL; Emamekhoo H; Averill SL; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Wells SA
Abdom Radiol (NY); 2018 Sep; 43(9):2446-2454. PubMed ID: 29464274
[TBL] [Abstract] [Full Text] [Related]
4. Cancer Incidence among Heart, kidney, and Liver Transplant Recipients in Taiwan.
Lee KF; Tsai YT; Lin CY; Hsieh CB; Wu ST; Ke HY; Lin YC; Lin FY; Lee WH; Tsai CS
PLoS One; 2016; 11(5):e0155602. PubMed ID: 27196400
[TBL] [Abstract] [Full Text] [Related]
